Chronic Leukemia

Chronic Leukemia News

  • EHA 2018 Survival Longer With Obinutuzumab Compared to Rituximab in CLL New longer-term results with overall survival data confirm the superiority of the newer agent over the earlier-generation anti-CD20 drug rituximab for previously untreated chronic lymphocytic leukemia (CLL).
  • IWMF 2018 New Drugs Poised to Expand Treatment Horizons in WM New drug combinations and pathways continue to be mined in an effort to expand treatment horizons for control of a rare lymphoma and extend quality of life for patients over many years to come.

Chronic Leukemia Perspective

  • EHA 2018 Read clinically focused news coverage of key developments from EHA 2018
  • A 71-Year-Old Man With Malaise: USMLE Question A 71-year-old man presents with fatigue and malaise over the past three months. He also reports a 10 lbs weight loss. What's causing these symptoms?


читайте здесь